Kotak Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Kotak Healthcare Fund - Regular (G)
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹233 Cr | ₹481 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 08 Nov 2021 | 11 Dec 2023 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | NIFTY Healthcare TRI |
| Turn Over | % | % |
| Expense Ratio | 2.35 | 2.39 |
| Manager | Rohan Korde | Abhishek Bisen |
| ISIN Code | INF00XX01BL5 | INF174KA1PW4 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Kotak Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Month | -2.44% | -1.43% |
| 6 Month | 1.71% | 5.01% |
| 1 Year | -1.77% | 2.56% |
| 3 Year | 19.23% | - |
| 5 Year | - | - |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| 6 Month | -1.28% | 0.51% |
| 1 Year | 1.83% | 6.83% |
| 3 Year | 16.44% | - |
| 5 Year | - | - |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Year | 18.94% | 13.51% |
| 3 Year | 20.21% | - |
| 5 Year | - | - |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Standard Deviation | 15.64% | - |
| Sharp | 0.77% | - |
| Beta | 0.95% | - |
| Alpha | -2.74% | - |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Name | Rohan Korde | Abhishek Bisen |
| Total AUM | ₹4626 Cr | ₹0 Cr |
| Funds Managed | 10 | 33 |
| ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 3.94 | 10.31 |
| Large Cap | 32.04 | 27.75 |
| Mid Cap | 36.31 | 32.05 |
| Small Cap | 27.72 | 29.89 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 1.7 | 1.28 |
| Healthcare | 93.14 | 95.49 |
| Basic Materials | 2.87 | 3.23 |
| Industrials | 1.05 | - |
| Financial Services | 1.25 | - |
Top Comparisons
SBI Equity Savings Fund - Regular Plan - Growth
3Y Returns11.61%
UTI Conservative Hybrid Fund - Regular Plan - Growth Option
3Y Returns10.79%
ICICI Prudential Bond Fund - Growth
3Y Returns7.67%
HDFC Income Fund - Growth Option
3Y Returns6.9%
Bajaj Finserv Large and Mid Cap Fund - Reg (G)
3Y Returns0%
Quant Large and Mid Cap Fund-Growth
3Y Returns16.49%
Sundaram Aggressive Hybrid Fund (Formerly Known as Principal Hybrid Equity Fund)-Growth
3Y Returns12.79%
Mahindra Manulife Aggressive Hybrid Fund - Regular Plan - Growth
3Y Returns16.64%